Related Experiment Video
Updated: Aug 4, 2026

12:11
ELIME (Enzyme Linked Immuno Magnetic Electrochemical) Method for Mycotoxin Detection
Published on: October 23, 2009
Gentamicin enzyme-linked immunosorbent assay for microdialysis samples
1Department of Clinical Pharmacy, University of Tennessee, College of Pharmacy, Memphis, TN 38163, USA. shanes@utmem.edu.
Therapeutic Drug Monitoring
|January 22, 2002
Summary
A new enzyme-linked immunosorbent assay (ELISA) accurately quantifies gentamicin in microdialysis samples. This sensitive method offers a valuable alternative for researchers needing precise gentamicin analysis with minimal sample volume.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Biomedical Engineering
Background:
- Gentamicin is an important antibiotic with a narrow therapeutic index.
- Accurate measurement of gentamicin in biological fluids is crucial for therapeutic drug monitoring.
- Microdialysis allows for in vivo sampling but often yields small sample volumes, posing analytical challenges.
Purpose of the Study:
- To evaluate a commercial gentamicin enzyme-linked immunosorbent assay (ELISA) for quantitative analysis in microdialysis samples.
- To determine the assay's accuracy, precision, sensitivity, and validity for this specific application.
- To establish a potentially superior alternative to existing gentamicin assay methods.
Main Methods:
- Utilized a commercially available gentamicin ELISA kit.
- Performed quantitative analysis of gentamicin concentrations in prepared microdialysis fluid samples.
- Assessed assay performance metrics including accuracy and precision across a defined concentration range.
Main Results:
- The gentamicin ELISA demonstrated good accuracy and precision.
- The assay was effective in the concentration range of 100 to 967 pg/mL.
- The method proved to be highly sensitive and valid for microdialysis samples.
Conclusions:
- The developed quantitative ELISA is a sensitive and valid method for measuring gentamicin in microdialysis samples.
- This ELISA assay presents a viable alternative for gentamicin analysis, especially when sample volume is limited.
- The assay overcomes limitations of other methods regarding sample volume requirements and sensitivity.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

